Braftovi 75 mg hard capsules clinical trials

C4221008 - A Phase 2, Open-label Study of Encorafenib + Binimetinib in Patients with BRAFV600-mutant Non-small Cell Lung Cancer

This study is looking at two drugs, encorafenib and binimetinib, for a type of lung cancer called non-small cell lung cancer. It's for patients whose cancer has a specific change called a BRAFV600 mutation. Researchers want to see how well these drugs shrink the cancer.